Author | Nitin Jain, MD | OncLive

Author | Nitin Jain, MD

Articles

Dr. Jain on the Combination of Venetoclax and Ibrutinib in CLL

January 12, 2018

Video

Nitin Jain, MD, assistant professor, Department of Leukemia, The University of Texas MD Anderson Cancer Center, discusses the combination of venetoclax (Venclexta) and ibrutinib (Imbruvica) in chronic lymphocytic leukemia (CLL).

Dr. Jain Discusses Treatment of Richter's Transformation in CLL

May 08, 2017

Video

Nitin Jain, MD, assistant professor, Department of Leukemia, The University of Texas MD Anderson Cancer Center, discusses the treatment of patients with chronic lymphocytic leukemia who have developed Richter’s transformation.

Dr. Jain on PD-1 Expression in Nivolumab/Ibrutinib Combination in CLL

February 24, 2017

Video

Nitin Jain, MD, assistant professor, Department of Leukemia, The University of Texas MD Anderson Cancer Center, discusses PD-1 expression in patients with chronic lymphocytic leukemia (CLL) who were treated with the combination of nivolumab (Opdivo) and ibrutinib (Imbruvica).

Dr. Jain on the Combination of Idelalisib and Rituximab for Older Patients With CLL

November 26, 2014

Video

Nitin Jain, MD, assistant professor, Department of Leukemia, The University of Texas MD Anderson Cancer Center, discusses the efficacy and safety of the combination of idelalisib and rituximab for older patients with chronic lymphocytic leukemia.

x